Found 14 matching trials
OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time NA Monotherapy with a P2Y12 inhibitor after a minimum period of DAPT following...
Show More Location
General Hospital of Northern Theater Command
Learn More & Join Trial
OCT or Angiography Guided De-escalation of DAPT EARLY_PHASE1 Optical coherence tomography (OCT) offers a high-resolution intravascular i...
Show More Location
Northern Hospital
Learn More & Join Trial
The Switching Antiplatelet-9 (SWAP-9) Study PHASE4 The purpose of this study is to compare the pharmacodynamic effects of ABCD...
Show More Location
University of Florida
Learn More & Join Trial
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study PHASE4 Dual antiplatelet therapy (DAPT) with low-dose aspirin and a P2Y12 inhibito...
Show More Location
University of Florida
Learn More & Join Trial
De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS PHASE3 High bleeding risk (HBR) patients, comprising up to 50% of those presenting...
Show More Location
Azienda Ospedaliera Universitaria Gaetano Martino
Learn More & Join Trial
Implementing Precision Medicine Approaches to Guide Anti-platelet Selection PHASE4 The study aims to determine the feasibility and clinical utility of incorpo...
Show More Location
LAC+USC Medical Center
Learn More & Join Trial
Ticagrelor De-escalation Strategy in AMI Patients PHASE4 DAPT de-escalation strategies to reduce bleeding include de-escalation of D...
Show More Location
DongA University Hospital
Learn More & Join Trial
Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR PHASE4 The aim of this study is to assess the safety and efficacy of the CYP2C19 g...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting PHASE4 Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary ...
Show More Learn More & Join Trial
Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome PHASE3 Patients who suffered from acute coronary syndrome (ACS) are usually treate...
Show More Location
Hopital Pitié Salpetrière
Learn More & Join Trial